학술논문
Clinical evaluation of sparfloxacin for the treatment of paranasal sinusitis / 副鼻腔炎に対するSparfloxacinの臨床的検討
Document Type
Journal Article
Author
Akihiro UCHIZONO; Akira TOHNAI; Atsushi SHINKAWA; Ginichiro ICHIKAWA; Haruo ITO; Hideki OKAZAKI; Hideshige KIMURA; Hideyo ASAI; Hiroko ISAJI; Hirosato MIYAKE; Hiroshi WATANABE; Hiroshi YAMASHITA; Hitoshi OGINO; Junichiro SHIMADA; Katsuhiro HIRAKAWA; Kazuhiko GOTO; Keiko KANESADA; Kohichi DEGUCHI; Kohji AJISAKA; Kohji SERA; Kozo FUKAMI; Mamoru TSUDA; Masaru OHYAMA; Masashi WADA; Masayoshi OZAKI; Minoru ISHIDA; Mitsuaki INAGAKI; Naoya MIYAMOTO; Ototaka KAKI; Ryuji KIYOTA; Shunkichi BABA; Soichiro NAGATA; Syozo KAWAMURA; Takatsugu ITABASHI; Takatsugu KATAOKA; Takayuki SHIRAISHI; Takehiro KOBAYASHI; Takeshi MARUO; Tetsuya SHIMA; Tetsuyasu HIRATA; Toru MATSUNAGA; Toru SEKITANI; Yasuo HARADA; Yasuo IWABUCHI; Yohichi MASUMITSU; Yutaka OGAWA; 三宅 浩郷; 世良 公志; 丸尾 猛; 伊佐治 広子; 伊藤 晴夫; 兼定 啓子; 内薗 明裕; 出口 浩一; 原田 康夫; 和田 昌士; 増満 洋一; 大山 勝; 宮本 直哉; 小川 裕; 小林 武弘; 尾崎 正義; 山下 裕司; 岡崎 英紀; 岩淵 康雄; 島 哲也; 島田 純一郎; 市川 銀一郎; 平川 勝洋; 平田 哲康; 後藤 和彦; 新川 敦; 木村 栄成; 東内 朗; 松永 亨; 板橋 隆嗣; 柿 音高; 永田 総一郎; 河村 正三; 津田 守; 浅井 英世; 深水 浩三; 清田 隆二; 渡辺 洋; 片岡 隆嗣; 白石 孝之; 石田 稔; 稲垣 光昭; 荻野 仁; 関谷 透; 馬場 駿吉; 鯵坂 孝二
Source
耳鼻と臨床 / jibi to rinsho. 1991, 37(5):961
Subject
Language
Japanese
ISSN
0447-7227
2185-1034
2185-1034
Abstract
Sparfloxacin (SPFX) was evaluated for its efficacy, safety and usefulness in the treatment of paranasal sinusitis. SPFX was administered in single or divided doses of 200mg to 300mg daily.The efficacy rate judged by the doctor in charge was 87.0% in cases of acute paranasal sinusitis, 74.1% in cases of acute exacerbated paranasal sinusitis, 66.7% in cases of chronic paranasal sinusitis and 80.5% in all cases. The efficacy rate judged by the committee was 87.0% in acute cases, 66.7% in acute exacerbated cases, 66.7% in chronic cases and 78.0% in all cases.The bacteriological eradication rate was 93.2% in gram-positive bacteria, 100% in gram-negative bacteria, 80.0% in anaerobic bacteria and 94.4% in all bacteria.Side effects were observed in 5 cases and abnormal clinical laboratory findings occurred in 3 cases. The rate of usefulness judged by the doctor in charge was 85.1% in acute cases, 63.0% in acute exacerbated cases, 66.7% in chronic cases and 75.9% in all cases.These results indicate that SPFX is useful in the treatment of paranasal sinusitis.